MIL is found in 1 entries

MIL as free ligands, exist in 1 entries. Examples include 1TLM,

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Identifiers 2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile
Formula C12 H9 N3 O
Molecular Weight 211.22 g/mol
Type non-polymer
Isomeric SMILES Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N
InChI InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)

Chemical Details

Formal Charge 0
Atom Count 25
Chiral Atom Count 0
Chiral Atoms
Bond Count 26
Aromatic Bond Count 13

Drug Info: DrugBank

DrugBank ID DB00235   (Stereoisomeric match)
Name Milrinone
Groups approved
Description A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the ionotropic potency of amrinone. [PubChem]
  • 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
  • Milrinona
  • Milrinone
  • Milrinonum
Salts Milrinone Lactate
Brand Names
  • Apo-milrinone Injectable
  • Milrinone Injection
  • Milrinone Lactate
  • Milrinone Lactate In Dextrose
  • Milrinone Lactate Injection
  • Primacor Injection 1mg/ml
  • Corotrop
  • Corotrope
  • Milrila
  • Primacor
Affected Organism Humans and other mammals
Indication Indicated for the treatment of congestive heart failure.
Pharmacology Milrinone, a synthetic dimethylxanthine derivative structurally related to theophylline and caffeine, is used in the treatment of peripheral vascular diseases and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Mechanism of action Milrinone inhibits erythrocyte phosphodiesterase, resulting in an increase in erythrocyte cAMP activity. Subsequently, the erythrocyte membrane becomes more resistant to deformity. Along with erythrocyte activity, Milrinone also decreases blood viscosity by reducing plasma fibrinogen concentrations and increasing fibrinolytic activity.
Route of administration intravenous
  • Platelet Aggregation Inhibitors
  • Cardiotonic Agents
  • Phosphodiesterase 3 Inhibitors
  • Vasodilator Agents
ATC-Code C01CE02
AHFS-Code 24:04.08
CAS number 78415-72-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682